Suffolk Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-114,244	Closed	-$9.11M	–	123
2017 Q2	$9.11M	Sell	114,244 -7,287	-6%	-$581K	1.2%	40
2017 Q1	$6.23M	Buy	+121,531	New	+$6.23M	0.83%	47